|
|
Volumn 6, Issue 3, 2006, Pages 196-201
|
|
Do all patients with metastatic colorectal cancer need chemotherapy until disease progression
|
|
Author keywords
Chemotherapy free interval; FOLFOX4; FOLFOX7; Reintroduction
|
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
RALTITREXED;
BOLUS INJECTION;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTINUOUS INFUSION;
DEHYDRATION;
DIARRHEA;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FEVER;
DRUG INDICATION;
DRUG INTERMITTENT THERAPY;
DRUG MEGADOSE;
DRUG SAFETY;
FOLLOW UP;
HAND FOOT SYNDROME;
HUMAN;
MAINTENANCE THERAPY;
METASTASIS;
NAUSEA AND VOMITING;
NEUROTOXICITY;
NEUTROPENIA;
OVERALL SURVIVAL;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
PROGNOSIS;
RISK REDUCTION;
SENSORY NEUROPATHY;
SHORT SURVEY;
STOMATITIS;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TUMOR GROWTH;
|
|
EID: 33750190310
PISSN: 15330028
EISSN: None
Source Type: Journal
DOI: 10.3816/CCC.2006.n.035 Document Type: Review |
|
Times cited : (6)
|
|
References (4)
|
